Centralized retinoblastoma program achieves high survival, eye-salvage rates

A retrospective cohort study reviewed 601 children (1000 affected eyes) with retinoblastoma treated over two decades at a centralized multidisciplinary center in Jordan that used telemedicine and an international twinning partnership, drawing referrals from 15 countries. The study reported an overall eye salvage rate of 61% (74.4% among conservatively treated eyes, ranging from 98% in Group A to 17% in Group E), metastasis in 4.3% and secondary malignancy in 1.2% of patients at median 120-month follow-up, and 5-year overall survival of 96%. The authors concluded that this centralized model achieved survival and globe-preservation outcomes comparable to high-income settings despite resource constraints.

Most relevant for: Clinicians managing retinoblastoma in resource-limited settings, including those involved in referral, globe-salvage decision-making, or multidisciplinary retinoblastoma care networks.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.